MiR-125b enhances autophagic flux to improve septic cardiomyopathy via targeting STAT3/HMGB1.

MLA

Yu, Ying, et al. “MiR-125b Enhances Autophagic Flux to Improve Septic Cardiomyopathy via Targeting STAT3/HMGB1.” Experimental Cell Research, vol. 409, no. 2, Dec. 2021, p. 112842. EBSCOhost, https://doi.org/10.1016/j.yexcr.2021.112842.

APA

Yu, Y., Ou-Yang, W.-X., Zhang, H., Jiang, T., Tang, L., Tan, Y.-F., Luo, H.-Y., Xiao, Z.-H., & Li, S.-J. (2021). MiR-125b enhances autophagic flux to improve septic cardiomyopathy via targeting STAT3/HMGB1. Experimental Cell Research, 409(2), 112842. https://doi.org/10.1016/j.yexcr.2021.112842

Chicago

Yu, Ying, Wen-Xian Ou-Yang, Hui Zhang, Tao Jiang, Lian Tang, Yan-Fang Tan, Hai-Yan Luo, Zheng-Hui Xiao, and Shuang-Jie Li. 2021. “MiR-125b Enhances Autophagic Flux to Improve Septic Cardiomyopathy via Targeting STAT3/HMGB1.” Experimental Cell Research 409 (2): 112842. doi:10.1016/j.yexcr.2021.112842.